Work

175 Nanomolar potency 3-carboxy-2-methylbenzofuran pendrin inhibitors for treatment of cystic fibrosis

Year: 2023

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(23)01106-2

Authors: R. Master, L. de Souza Goncalves, J. Karmakar, M.O. Anderson, O. Cil

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institutes of Health

OpenAlex ID: W4387746382

FWCI:

Cites:

Cited by:

Related to: 10